Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage ...

A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...

Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...

UVA scientists discovered a molecule that blocks a key gene that drives glioblastoma, offering hope for a new treatment ...

Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

By targeting a cancer-driving pathway at multiple steps, a triple therapy stopped pancreatic tumors from developing ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Gene therapy represents an innovative approach to treating cancer by directly modifying the genetic material within tumour cells, thereby utilising molecular mechanisms to inhibit tumour growth or ...